Rezultati pretraživanja
  1. Heron Therapeutics Lowered to “Buy” at ValuEngine

  2. : New SEC Filing for HRTX: Form SC 13G/A (No. 0000834237-20-005426):

  3. 5. velj

    Heron Therapeutics Stock Price Up 6.8%

  4. 4. velj

    Added 1% position . Holding 4% position with average price of $22.92

  5. 3. velj
    Odgovor korisnicima

    Truly unfortunate. FDA should be doing their civil duty to help patients avoid opioid use if there are better options in the pipeline but I think patience will pay off if you’re a holder. A lot of synergies for their launch alongside CINVANTI. Should begin to move soon.

  6. 3. velj

    crickets. SHOULD prioritize approval of non opioid pain meds, yet it's becoming clearer and clearer that this NOT among its batch of early approvals it has been handing out. Shame.

  7. 2. velj
  8. 2. velj
  9. 1. velj

    Introducing monthly update series of main portfolio Focus on small/mid cap biotech/SaaS/life sciences. YTD: Portfolio +4.12% SPY -0.16% About 5% in cash. From biggest to smallest position:

  10. 1. velj
  11. 31. sij

    Commented on - Heron Therapeutics:?sht=q4zmm5&shu=aozs Looking Solid Heading Into 2020.

  12. 31. sij

    Adding incrementally

  13. 31. sij

    Thurs (1/30/20) highest faded trading range compared to open > 80% (Min $5 & Vol 750K, Opt Min Vol 250 in any strike):

  14. 31. sij

    Thurs (1/30/20) highest % below OR 30-min low, Up/Avg loss of today's thirteen 30-min bars, G/L % in final 30-Min & Trading range % (Min $5, Vol > 750K, Opt Vol in any strike > 500):

  15. 29. sij
  16. 29. sij

    FY2019 EPS Estimates for Heron Therapeutics Inc Lifted by Svb Leerink

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.